In the context of CXCR2+ neutrophil depletion genetically or pharmacologically, PDAC liver metastasis was remarkably reduced, along with significantly prolonged tumor-free survival of PDAC mouse models (67). The gene discussed is CXCR2; the disease is neoplasm.